CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Growth Rate (CA

Posted by Neel Patel on December 22nd, 2017

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece.

Access Full Report: https://www.algororeports.com/reports/countryfocus-healthcare-regulatory-and-reimbursement-landscape-greece-1307866

Summary

 the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Greece. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, 

The value of the pharmaceuticals market decreased from .8 billion in 2009 to .8 billion in 2016 at a negative Compound Annual Growth Rate (CAGR) of 6.3%, and this value is expected to increase further to .9 billion in 2021. The medical device market was worth .3 billion in 2009 and .56 billion in 2016. It is forecast to grow at a CAGR of 3.7% from .62 billion in 2017 to .87 billion in 2021.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Greece, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, Sanofi, Astra Zeneca and GlaxoSmithKline (GSK). Profiles and SWOT analyses of the major players in the medical device market: Sanofi, Roche, Essilor and Alcon.
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare environment, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Greek healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Greece’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Greece’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership.

Contact Us

Neel Patel
Manager - Business Development
www.algororeports.com
neel.patel@algororeports.com
Ph: +1-972-591-8785 (US)
info@algororeports.com